Welcome to the UPF Digital Repository

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

Show simple item record

dc.contributor.author Çubut, Cankut
dc.contributor.author Hidalgo, Marta R.
dc.contributor.author Amadoz, Alicia
dc.contributor.author Rian, Kinza
dc.contributor.author Salavert, Francisco
dc.contributor.author Pujana, Miguel Angel
dc.contributor.author Mateo, Francesca
dc.contributor.author Herranz Ors, Carmen, 1992-
dc.contributor.author Carbonell-Caballero, Jose
dc.contributor.author Dopazo, Joaquín
dc.date.accessioned 2020-04-07T08:47:45Z
dc.date.available 2020-04-07T08:47:45Z
dc.date.issued 2019
dc.identifier.citation Çubuk C, Hidalgo MR, Amadoz A, Rian K, Salavert F, Pujana MA, Mateo F, Herranz C, Carbonell-Caballero J, Dopazo J. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. NPJ Syst Biol Appl. 2019; 5:7. DOI: 10.1038/s41540-019-0087-2
dc.identifier.issn 2056-7189
dc.identifier.uri http://hdl.handle.net/10230/44175
dc.description.abstract In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions.
dc.description.sponsorship This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 and “Plataforma de Bioinformática” PT17/0009/0006 from the ISCIII, all co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1–2015–1 ELIXIR-EXCELERATE (ref. 676559) and EU FP7-People ITN Marie Curie Project (ref 316861). The article was previously published as a preprint: Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Kinza Rian, Francisco Salavert, Miguel Angel Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell Caballero, Joaquin Dopazo. 2018. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. bioRxiv https://doi.org/10.1101/367334.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Nature Research
dc.relation.ispartof NPJ Syst Biol Appl. 2019; 5:7
dc.rights © The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.title Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1038/s41540-019-0087-2
dc.subject.keyword Cancer
dc.subject.keyword Metabolic engineering
dc.subject.keyword Software
dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/SAF2017–88908-R
dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/676559
dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/316861
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking